Legal & General Group PLC Alector, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Alector, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 66,172 shares of ALEC stock, worth $123,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,172

Previous 63,531 4.16%

Holding current value

$123,741

Previous $296,000 57.77%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$1.72 - $6.06 $4,542 - $16,004	2,641 Added 4.16%	66,172 $125,000
Q3 2024 Nov 14, 2024	SELL	$4.34 - $6.58 $733 - $1,112	-169 Reduced 0.27%	63,531 $296,000
Q2 2024 Aug 14, 2024	BUY	$4.19 - $6.23 $14,019 - $20,845	3,346 Added 5.54%	63,700 $289,000
Q1 2024 Jul 01, 2024	BUY	$5.69 - $8.08 $8,495 - $12,063	1,493 Added 2.54%	60,354 $363,000
Q1 2024 May 14, 2024	SELL	$5.69 - $8.08 $4,443 - $6,310	-781 Reduced 1.31%	58,861 $354,000
Q4 2023 Feb 15, 2024	SELL	$3.77 - $8.39 $637 - $1,417	-169 Reduced 0.28%	59,642 $475,000
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $28,646 - $48,313	5,509 Added 10.15%	59,811 $387,000
Q2 2023 Aug 14, 2023	SELL	$5.86 - $7.93 $8,930 - $12,085	-1,524 Reduced 2.73%	54,302 $326,000
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $14,765 - $24,836	2,524 Added 4.74%	55,826 $345,000
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $10,691 - $14,840	1,554 Added 3.0%	53,302 $491,000
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $11,531 - $18,585	1,408 Added 2.8%	51,748 $490,000
Q2 2022 Aug 22, 2022	BUY	$7.65 - $14.24 $726 - $1,352	95 Added 0.19%	50,340 $512,000
Q1 2022 May 16, 2022	BUY	$13.02 - $20.78 $6,431 - $10,265	494 Added 0.99%	50,245 $716,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $31,230 - $41,221	1,614 Added 3.35%	49,751 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $58,779 - $107,215	2,715 Added 5.98%	48,137 $1.1 Million
Q2 2021 Aug 12, 2021	BUY	$15.5 - $22.48 $262,198 - $380,271	16,916 Added 59.34%	45,422 $947,000
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $74 - $111	-5 Reduced 0.02%	28,506 $575,000
Q3 2020 Nov 13, 2020	BUY	$10.54 - $24.96 $160,850 - $380,914	15,261 Added 115.18%	28,511 $301,000
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $167,524 - $253,622	7,660 Added 137.03%	13,250 $324,000
Q1 2020 May 14, 2020	SELL	$16.25 - $35.28 $10,643 - $23,108	-655 Reduced 10.49%	5,590 $134,000
Q4 2019 Feb 13, 2020	BUY	$14.17 - $20.3 $17,004 - $24,360	1,200 Added 23.79%	6,245 $108,000
Q3 2019 Nov 13, 2019	BUY	$14.42 - $22.2 $49,143 - $75,657	3,408 Added 208.19%	5,045 $73,000
Q2 2019 Aug 14, 2019	BUY	$16.26 - $26.42 $11,073 - $17,992	681 Added 71.23%	1,637 $31,000
Q1 2019 May 15, 2019	BUY	$15.97 - $22.5 $15,267 - $21,510	956 New	956 $18,000

Others Institutions Holding ALEC

# of Institutions

155

Shares Held

55M

Call Options Held

39.7K

Put Options Held

51K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $154M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Alector, Inc. Transaction History